STAT3 and glioma: In order to assess the potential therapeutic uses of NLP-EXOSOME COMPLEX-formulated siRNA both in vitro and in vivo, we specifically targeted STAT3, as it is known to be highly active in glioma and difficult to treat with traditional drugs.